Reckitt Benckiser(US:RBGLY) Prnewswireยท2025-07-29 12:45Core Viewpoint - A class action securities lawsuit has been filed against Reckitt Benckiser Group plc, alleging securities fraud that affected investors between January 13, 2021, and July 28, 2024 [1][2] Group 1: Allegations - The lawsuit claims that Reckitt Benckiser Group plc made false statements regarding the safety of its cow's milk-based formula, Enfamil, particularly concerning the increased risk of necrotizing enterocolitis (NEC) in preterm infants [2] - It is alleged that these false statements misrepresented the impact on Reckitt's sales of Enfamil and the company's exposure to legal claims [2] - The defendants' positive statements about the company's business and prospects were claimed to be materially false and misleading [2] Group 2: Legal Process - Investors who suffered losses during the specified timeframe have until August 4, 2025, to request appointment as lead plaintiff in the lawsuit [3] - Participation in the lawsuit does not require serving as a lead plaintiff, and class members may be entitled to compensation without any out-of-pocket costs [3] Group 3: Firm Background - Levi & Korsinsky, LLP has a history of securing hundreds of millions of dollars for shareholders and is recognized as one of the top securities litigation firms in the United States [4]